(1) DISCLOSEABLE TRANSACTION INVOLVING ACQUISITION OF 91% (WITH PUT AND CALL OPTIONS TO ACQUIRE ADDITIONAL 5%) OF UNIVERSAL PHARMACEUTICAL LABORATORIES, LIMITED AND PUT AND CALL OPTIONS TO ACQUIRE PROPERTIES AND (2) POST-COMPLETION CONTINUING CONNECTED TRANSACTIONS (in PDF)
PROPOSALS FOR GENERAL MANDATE TO ISSUE SHARES, GENERAL MANDATE TO REPURCHASE SHARES, FINAL DIVIDEND, RE-ELECTION OF DIRECTORS, APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR, REMUNERATION TO DIRECTORS, REFRESHMENT OF THE SCHEME MANDATE LIMIT OF THE SHARE OPTION SCHEME AND NOTICE OF ANNUAL GENERAL MEETING (in PDF)
DISCLAIMER: irasia.com Ltd makes no guarantee as to the accuracy or completeness of any
information provided on this website. Under no circumstances shall irasia.com Ltd be liable
for damages resulting from the use of the information provided on this website.
TRADEMARK & COPYRIGHT: All intellectual property rights subsisting in the contents of
this website belong to irasia.com Ltd or have been lawfully licensed to irasia.com Ltd for
use on this website. All rights under applicable laws are hereby reserved. Reproduction
of this website in whole or in part without the express written permission of irasia.com Ltd
is strictly prohibited.
TERMS OF USE: Please read the Terms of Use governing the use
of our website.